These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20619877)

  • 1. Predicting variability of aquatic concentrations of human pharmaceuticals.
    Kostich MS; Batt AL; Glassmeyer ST; Lazorchak JM
    Sci Total Environ; 2010 Sep; 408(20):4504-10. PubMed ID: 20619877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks to aquatic organisms posed by human pharmaceutical use.
    Kostich MS; Lazorchak JM
    Sci Total Environ; 2008 Jan; 389(2-3):329-39. PubMed ID: 17936335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
    Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
    Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
    Liebig M; Moltmann JF; Knacker T
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmaceuticals in US surface waters: a human health risk assessment.
    Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
    Cunningham VL; Binks SP; Olson MJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the PhATE™ model.
    Cunningham VL; D'Aco VJ; Pfeiffer D; Anderson PD; Buzby ME; Hannah RE; Jahnke J; Parke NJ
    Integr Environ Assess Manag; 2012 Jul; 8(3):530-42. PubMed ID: 22162313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data. Part 1: Estimation of the usage of drugs in local communities.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Environ Pollut; 2009 Jun; 157(6):1773-7. PubMed ID: 19324480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing emissions of active pharmaceutical ingredients from manufacturing facilities: an environmental quality standard approach.
    Murray-Smith RJ; Coombe VT; Grönlund MH; Waern F; Baird JA
    Integr Environ Assess Manag; 2012 Apr; 8(2):320-30. PubMed ID: 22057894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain.
    Ortiz de García S; Pinto Pinto G; García Encina P; Irusta Mata R
    Sci Total Environ; 2013 Feb; 444():451-65. PubMed ID: 23287535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose?
    Burns EE; Thomas-Oates J; Kolpin DW; Furlong ET; Boxall ABA
    Environ Toxicol Chem; 2017 Oct; 36(10):2823-2832. PubMed ID: 28477358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.
    Zuccato E; Castiglioni S; Fanelli R
    J Hazard Mater; 2005 Jul; 122(3):205-9. PubMed ID: 15967275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
    Besse JP; Garric J
    Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and evaluation of computer models for predicting environmental concentrations of pharmaceuticals and veterinary products in the Nordic environment.
    Wajsman D; Rudén C
    J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):85-97. PubMed ID: 16030525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening analysis of human pharmaceutical compounds in U.S. surface waters.
    Anderson PD; D'Aco VJ; Shanahan P; Chapra SC; Buzby ME; Cunningham VL; Duplessie BM; Hayes EP; Mastrocco FJ; Parke NJ; Rader JC; Samuelian JH; Schwab BW
    Environ Sci Technol; 2004 Feb; 38(3):838-49. PubMed ID: 14968872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical concentrations in screened municipal wastewaters in Victoria, British Columbia: A comparison with prescription rates and predicted concentrations.
    Saunders LJ; Mazumder A; Lowe CJ
    Environ Toxicol Chem; 2016 Apr; 35(4):919-29. PubMed ID: 26363402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of a model to estimate wastewater treatment plant prescription pharmaceutical influent loadings and concentrations.
    Ottmar KJ; Colosi LM; Smith JA
    Bull Environ Contam Toxicol; 2010 May; 84(5):507-12. PubMed ID: 20411240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment.
    Lin AY; Panchangam SC; Chen HY
    J Environ Monit; 2010 Jan; 12(1):261-70. PubMed ID: 20082021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying targets of potential concern by a screening level ecological risk assessment of human use pharmaceuticals in China.
    Bu Q; Cao Y; Yu G; He X; Zhang H; Sun J; Yun M; Cao Z
    Chemosphere; 2020 May; 246():125818. PubMed ID: 31918110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.